Back to results
US 12,213,985 B2Granted
Oral cannabinoid formulations
AssigneeJazz Pharmaceuticals Research UK Limited
InventorHarshit Shah
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cannabinoid containing oral solution. Preferably the oral solution comprises a cannabinoid, a lipid solvent, a sweetener and ethanol, characterised in that the sweetener is an ultrahigh potency sweetener.
Claims27
A method of treating a disease or disorder, the method comprising orally administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical formulation comprising:
- cannabidiol (CBD);
- a lipid solvent;
- an ultrahigh potency sweetener;
- and
- ethanol, wherein ethanol has a concentration of less than about 3% v/v, and
- wherein the disease or disorder is epilepsy or a syndrome associated therewith, schizophrenia, tuberous sclerosis complex, brain tumors, neuropathic pain, cannabis use disorder. post-traumatic stress disorder, anxiety, early psychosis, Alzheimer's Disease, or autism.
3 more elements
Dependencies are inferred from the claim text.